Literature DB >> 24600032

Enhancement of T cell responses as a result of synergy between lower doses of radiation and T cell stimulation.

Lisa K Spary1, Saly Al-Taei, Josephine Salimu, Alexander D Cook, Ann Ager, H Angharad Watson, Aled Clayton, John Staffurth, Malcolm D Mason, Zsuzsanna Tabi.   

Abstract

As a side effect of cancer radiotherapy, immune cells receive varying doses of radiation. Whereas high doses of radiation (>10 Gy) can lead to lymphopenia, lower radiation doses (2-4 Gy) represent a valid treatment option in some hematological cancers, triggering clinically relevant immunological changes. Based on our earlier observations, we hypothesized that lower radiation doses have a direct positive effect on T cells. In this study, we show that 0.6-2.4 Gy radiation enhances proliferation and IFN-γ production of PBMC or purified T cells induced by stimulation via the TCR. Radiation with 1.2 Gy also lowered T cell activation threshold and broadened the Th1 cytokine profile. Although radiation alone did not activate T cells, when followed by TCR stimulation, ERK1/2 and Akt phosphorylation increased above that induced by stimulation alone. These changes were followed by an early increase in glucose uptake. Naive (CD45RA(+)) or memory (CD45RA(-)) T cell responses to stimulation were boosted at similar rates by radiation. Whereas increased Ag-specific cytotoxic activity of a CD8(+) T cell line manifested in a 4-h assay (10-20% increase), highly significant (5- to 10-fold) differences in cytokine production were detected in 6-d Ag-stimulation assays of PBMC, probably as a net outcome of death of nonstimulated and enhanced response of Ag-stimulated T cells. T cells from patients receiving pelvic radiation (2.2-2.75 Gy) also displayed increased cytokine production when stimulated in vitro. We report in this study enhanced T cell function induced by synergistic radiation treatment, with potential physiological significance in a wide range of T cell responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24600032     DOI: 10.4049/jimmunol.1302736

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  T-cell receptor affinity in the age of cancer immunotherapy.

Authors:  Michele M Hoffmann; Jill E Slansky
Journal:  Mol Carcinog       Date:  2020-05-09       Impact factor: 4.784

Review 2.  Trial Watch: Radioimmunotherapy for oncological indications.

Authors:  Norma Bloy; Jonathan Pol; Gwenola Manic; Ilio Vitale; Alexander Eggermont; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-13       Impact factor: 8.110

3.  Rescue of CD8+ T cell vaccine memory following sublethal γ irradiation.

Authors:  Hugh I McFarland; Julia D Berkson; Jay P Lee; Abdel G Elkahloun; Karen P Mason; Amy S Rosenberg
Journal:  Vaccine       Date:  2015-06-26       Impact factor: 3.641

Review 4.  A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment.

Authors:  Iske F van Luijk; Sharissa M Smith; Maria C Marte Ojeda; Arlene L Oei; Gemma G Kenter; Ekaterina S Jordanova
Journal:  J Clin Med       Date:  2022-04-19       Impact factor: 4.964

Review 5.  Cancer stem cells as targets for immunotherapy.

Authors:  Amy S Codd; Takayuki Kanaseki; Toshihiko Torigo; Zsuzsanna Tabi
Journal:  Immunology       Date:  2017-12-18       Impact factor: 7.397

6.  Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells.

Authors:  Samantha S Beauford; Anita Kumari; Charlie Garnett-Benson
Journal:  BMC Immunol       Date:  2020-04-16       Impact factor: 3.615

Review 7.  Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells.

Authors:  Saurabh Pratap Singh; Richa Singh; Om Prakash Gupta; Shalini Gupta; Madan Lal Brahma Bhatt
Journal:  J Oncol       Date:  2020-03-09       Impact factor: 4.375

8.  Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model.

Authors:  Surya Murty; Samuel T Haile; Corinne Beinat; Amin Aalipour; Israt S Alam; Tara Murty; Travis M Shaffer; Chirag B Patel; Edward E Graves; Crystal L Mackall; Sanjiv S Gambhir
Journal:  Oncoimmunology       Date:  2020-05-13       Impact factor: 8.110

Review 9.  Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance.

Authors:  Minhui Chen; Anurag K Singh; Elizabeth A Repasky
Journal:  Cancers (Basel)       Date:  2020-12-20       Impact factor: 6.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.